{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Eurocine Vaccines AB (publ)", "shortName": "EUROCINE VACCINES NAM.", "regularMarketPrice": 0.0812, "regularMarketChangePercent": -0.7334905, "messageBoardId": "finmb_1425508", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.56344086, "fiftyTwoWeekLow": 0.0532, "fiftyTwoWeekHigh": 0.186, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.028000005, "fiftyTwoWeekLowChangePercent": 0.52631587, "fiftyTwoWeekRange": "0.0532 - 0.186", "fiftyTwoWeekHighChange": -0.1048, "epsTrailingTwelveMonths": -0.1, "sharesOutstanding": 27791800, "bookValue": 2.851, "fiftyDayAverage": 0.087764, "fiftyDayAverageChange": -0.0065639988, "fiftyDayAverageChangePercent": -0.07479147, "twoHundredDayAverage": 0.090003, "twoHundredDayAverageChange": -0.008802995, "twoHundredDayAverageChangePercent": -0.097807795, "marketCap": 2625845, "priceToBook": 0.028481236, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1620194400000, "priceHint": 4, "regularMarketChange": -0.00059999526, "regularMarketTime": 1683871385, "regularMarketDayHigh": 0.0812, "regularMarketDayRange": "0.0812 - 0.0812", "regularMarketDayLow": 0.0812, "regularMarketVolume": 23000, "regularMarketPreviousClose": 0.0818, "bid": 0.0868, "ask": 0.112, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.0812, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "symbol": "8X4.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Nanna Svartz vAeg 4", "city": "Solna", "zip": "171 65", "country": "Sweden", "phone": "46 7 06 34 01 71", "website": "https://www.eurocine-vaccines.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Eurocine Vaccines AB (publ) engages in the development of vaccines in Sweden. It has a research and collaboration agreement with Spixia Biotechnology AB to develop, manufacture, and commercialize chlamydia vaccine candidates. The company was incorporated in 1999 and is based in Solna, Sweden.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Hans  Arwidsson Ph.D.", "age": 64, "title": "CEO, Pres & Director", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anna-Karin  Maltais", "title": "Chief Scientific Officer, VP of R&D and Member of Scientific Advisory Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}